Arcadia Biosciences, Inc. (NASDAQ:RKDA) Short Interest Update

Arcadia Biosciences, Inc. (NASDAQ:RKDA) was the target of a large decrease in short interest in the month of July. As of July 15th, there was short interest totaling 9,653 shares, a decrease of 58.6% from the June 30th total of 23,325 shares. Based on an average daily trading volume, of 133,939 shares, the days-to-cover ratio is currently 0.1 days. Currently, 0.5% of the company’s stock are short sold.

Arcadia Biosciences Price Performance

Shares of NASDAQ:RKDA traded up $0.01 during midday trading on Wednesday, hitting $0.64. 8,032 shares of the company’s stock were exchanged, compared to its average volume of 1,359,247. Arcadia Biosciences has a 12 month low of $0.59 and a 12 month high of $6.71. The company has a market cap of $1.39 million, a PE ratio of -0.11 and a beta of 0.54. The stock has a 50 day moving average price of $0.80 and a 200-day moving average price of $1.36.

Arcadia Biosciences (NASDAQ:RKDA) last announced its quarterly earnings results on Thursday, May 14th. The basic materials company reported ($2.11) earnings per share for the quarter, missing the consensus estimate of ($0.80) by ($1.31). The business had revenue of $1.10 million during the quarter, compared to the consensus estimate of $1.60 million. Arcadia Biosciences had a negative net margin of 195.94% and a negative return on equity of 113.73%.

Wall Street Analyst Weigh In

Separately, Weiss Ratings cut Arcadia Biosciences from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Thursday, June 25th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, the company presently has an average rating of “Sell”.

Arcadia Biosciences Company Profile

Arcadia Biosciences, Inc, founded in 2002 and headquartered in Davis, California, is an agricultural biotechnology company dedicated to developing crops and food ingredients that promote health and sustainability. By harnessing advanced genomics and precision‐breeding technologies, Arcadia creates proprietary trait platforms designed to enhance crop performance, nutritional value, and resilience to environmental stressors. The company’s scientific expertise focuses on non-transgenic approaches, enabling the delivery of novel traits without introducing foreign DNA.

Arcadia’s operations span two main segments: Crop Traits and Food Ingredients.